YS BIOPHARMA CO LTD (YS) Stock Analyst Ratings
USA - NASDAQ:YS - KYG9845F1090 - Common Stock
1.02 USD
+0.11 (+12.45%)
1.07 USD
+0.05 (+4.9%)
ChartMill assigns a Buy % Consensus number of 84% to YS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.26. This target is 317.5% above the current price.
YS was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about YS.
In the previous month the buy percentage consensus was at a similar level.
YS was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-11-13 | Noble Capital Markets | Initiate | Outperform |
YS BIOPHARMA CO LTD / YS FAQ
Can you provide the average price target for YS BIOPHARMA CO LTD stock?
9 analysts have analysed YS and the average price target is 4.26 USD. This implies a price increase of 317.5% is expected in the next year compared to the current price of 1.02.
What is the consensus rating for YS BIOPHARMA CO LTD (YS) stock?
The consensus rating for YS BIOPHARMA CO LTD (YS) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for YS stock?
The number of analysts covering YS BIOPHARMA CO LTD (YS) is 9.